Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study Evaluating the Impact of an Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients (>70 Years Old) Presenting With Cancer and Treated With Oral Therapy.

NCT07802847 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT07802847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study Evaluating the Impact of an Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients (>70 Years Old) Presenting With Cancer and Treated With Oral Therapy.
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2031
Enrollment
794 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, elderly, kidney cancer, lung cancer, prostate cancer, sarcoma